TITLE 77: PUBLIC HEALTH
CHAPTER X: DEPARTMENT OF HUMAN SERVICES
SUBCHAPTER d: LICENSURE
PART 2060 SUBSTANCE USE DISORDER TREATMENT AND INTERVENTION SERVICES
SECTION 2060.360 INFORMED CONSENT


 

Section 2060.360  Informed Consent

 

a)         Each organization shall have an informed consent procedure to obtain legally valid signed consent from the person or legal guardian for intervention or treatment services and that documents agreement to participate in those services, knowledge of the consequences of withdrawal from such services, and that allows for authorization or decline of the access to and/or release of confidential medical information.  Consent may be obtained electronically. 

 

b)         The informed consent must also acknowledge the right to a conflict-free choice of services from any licensed organization and an understanding of the potential risks and benefits of selected services.

 

c)         The informed consent shall contain a section that allows, as applicable, for authorization or decline (for self or significant others or family members) of participation in or the use of the following:

 

1)         Experimental medications;

 

2)         Experimental assessment procedures;

 

3)         Recording on audiovisual equipment;

 

4)         Participation in research projects; and

 

5)         Testing for HIV.

 

d)         The informed consent shall be signed and dated by the person receiving the service prior to the initiation of authorized intervention or treatment services.

 

e)         A copy of the informed consent shall be provided to the person receiving the service, upon request.

 

f)         The informed consent may be combined with the client/patient/resident rights document as referenced in Section 2060.365 if there are separate signature authorizations for each document.